Stay updated on Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Sign up to get notified when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.

Latest updates to the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA 2015 U.S. NIH Grant/Contract note and the rheumatoid arthritis topic were added, along with a related topics link to MedlinePlus Genetics. The revision label was updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check19 days agoChange DetectedThe page no longer lists the disease tag 'Rheumatoid arthritis' and the related topics section (MedlinePlus Genetics), removing key disease-specific context and external references.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe footer revision label changed from v3.6.4 to v3.6.5, representing a small update to the page's versioning descriptor without altering the displayed study details.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page adds 'Rheumatoid arthritis' as a related topic and links to MedlinePlus Genetics under related topics, and the page revision advances from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page’s related topics section loses the entries for Rheumatoid arthritis and MedlinePlus Genetics, decreasing the topic metadata associated with the study.SummaryDifference0.0%

- Check69 days agoChange DetectedA new release revision v3.6.3 was added and the previous v3.6.2 revision was removed, indicating an administrative update to the page release notes/metadata rather than any change to study details.SummaryDifference0.0%

Stay in the know with updates to Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upadacitinib vs Methotrexate in MTX-Naive RA: Clinical Trial page.